Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial.
Yuan-Bin ChenLin LinLei WuYinji XuJohannah Linda ShergisAnthony Lin ZhangZehuai WenChristopher WorsnopCliff Da CostaFrancis ThienCharlie C XuePublished in: International journal of chronic obstructive pulmonary disease (2020)
Compared with placebo, ginseng did not reduce the rate of acute COPD exacerbations over 12 months. It was safe and well tolerated by people with moderate to very severe COPD.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- liver failure
- drug induced
- respiratory failure
- cystic fibrosis
- high intensity
- early onset
- double blind
- hepatitis b virus
- phase iii
- clinical trial
- randomized controlled trial
- air pollution
- extracorporeal membrane oxygenation
- placebo controlled
- study protocol
- mechanical ventilation
- acute respiratory distress syndrome